Stock NTH NATURHOUSE HEALTH, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Naturhouse Health, S.A.

Equities

NTH

ES0105043006

Market Closed - BME
Other stock markets
 09:05:26 26/04/2024 pm IST 		5-day change 1st Jan Change
1.64 EUR -1.80% Intraday chart for Naturhouse Health, S.A. -0.61% +1.23%
15/03 Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • With a P/E ratio at 9.65 for the current year and 9.65 for next year, earnings multiples are highly attractive compared with competitors.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

Ratings chart - Surperformance

Sector: Other Specialty Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
NATURHOUSE HEALTH, S.A. Stock Naturhouse Health, S.A.
+1.23% 105M -
TRACTOR SUPPLY COMPANY Stock Tractor Supply Company
+27.38% 29.56B
A-
AVOLTA AG Stock Avolta AG
+4.90% 5.71B
B-
JARIR MARKETING COMPANY Stock Jarir Marketing Company
-11.42% 4.42B
C
JUMBO S.A. Stock Jumbo S.A.
+14.25% 4.17B
C+
GRUPO GIGANTE, S. A. B. DE C. V. Stock Grupo Gigante, S. A. B. de C. V.
+4.23% 1.85B -
B-
UPBOUND GROUP, INC. Stock Upbound Group, Inc.
-4.59% 1.77B
C+
WINMARK CORPORATION Stock Winmark Corporation
-13.78% 1.26B -
C
SALLY BEAUTY HOLDINGS, INC. Stock Sally Beauty Holdings, Inc.
-17.17% 1.15B
B-
MATAS A/S Stock Matas A/S
-2.08% 613M
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NTH Stock
  4. Ratings Naturhouse Health, S.A.